NCT06956014View on ClinicalTrials.gov

Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Low Back Pain

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions

Chronic Low Back Pain

Interventions

DRUG

VER-01

Standardized soft extract from Cannabis sativa DKJ127 L., cannabis flos (Cannabis flower), corresponding to 19 mg Δ9-Tetrahydrocannabinol (THC) per ml drug product

OTHER

Placebo

Comparator without active ingredient

All Listed Sponsors

lead

Vertanical GmbH

INDUSTRY